Key enzymes in the glycolytic pathway, including GLUT1, HK2, PFK1, PKM2 and LDH‐A, are overexpressed in sorafenib‐resistant HCC cell lines, which upregulates aerobic glycolysis.9, 10, 64. Here, SLC2A1 is linked to hepatocellular carcinoma.